http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020030314-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41ef34b13b05b0f6b7f08fb2479edadb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2019-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e7048888a003065aa84302d7b1f0198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6544569f517ae84a183f47de1011413e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0f4fb30e3506b4cf825e18641e7972f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45fa8d614fb267b4fcfb30a062acd236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2586b492faf26e4cf19a68a67d6840b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080de0e38fd451b3346b379168dbf535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df67be3dfa8dd1a5e4922d9a2b1331d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6304a3457b40f861a74f271001dce7b9
publicationDate 2020-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020030314-A1
titleOfInvention Early treatment of cmt disease
abstract The present invention provides methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A), by administering to a subject in need thereof a combination comprising baclofen, sorbitol and naltrexone, or a pharmaceutically acceptable salt thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11576908-B2
priorityDate 2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5485201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515

Total number of triples: 46.